Global Markets Direct

1 of 170
Sort By:
Per Page:
  • Neurofibromatoses Type I (Von Recklinghausen’s Disease) Pipeline Review H1 2017

    29 Dec, 2017  |  46 Pages
    Neurofibromatoses Type I (Von Recklinghausen’s Disease) - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type I - Pipeline Review, H2 2017, provides an overview of the Neurofibromatoses Type I (Genetic Dis...
    From
    $2,000.00
  • Wilson Disease Pipeline Review H1 2017

    29 Dec, 2017  |  46 Pages
    Wilson Disease - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Wilson Disease - Pipeline Review, H2 2017, provides an overview of the Wilson Disease (Genetic Disorders) pipeline landscape. Wilson disease is a rare autosomal re...
    From
    $2,000.00
  • Anemia in Chronic Kidney Disease (Renal Anemia) Pipeline Review H1 2017

    29 Dec, 2017  |  121 Pages
    Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2017, provides an overview of the Anemia in Chronic Kidney Di...
    From
    $2,000.00
  • Graves Diseases Pipeline Review H1 2017

    29 Dec, 2017  |  29 Pages
    Graves Diseases - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Pipeline Review, H2 2017, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape. Graves' disease is an immune syst...
    From
    $2,000.00
  • Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Pipeline Review H1 2017

    29 Dec, 2017  |  91 Pages
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H2 2017, provide...
    From
    $2,000.00